T. Moeslinger et Pg. Spieckermann, Urea-induced inducible nitric oxide synthase inhibition and macrophage proliferation, KIDNEY INT, 59, 2001, pp. S2-S8
Background. Atherosclerosis is a major cause of morbidity and mortality in
chronic renal failure and is associated with the proliferation of macrophag
es within atherosclerotic lesions.
Methods. Because the progression of atherosclerosis as a consequence of dec
reased nitric oxide (NO) synthesis has been described, we investigated the
correlation between the inhibition of inducible NO synthase (iNOS) by urea,
macrophage proliferation as assayed by cell counting, tritiated-thymidine
incorporation and measurement of cell protein, and macrophage apoptosis.
Results. Urea induces a dose-dependent inhibition of inducible NO synthesis
in lipopolysaccharide-stimulated mouse macrophages (RAW 264.7) with concom
itant macrophage proliferation. Macrophage proliferation as determined by c
ell counting became statistically significant at 60 nmol/L urea correspondi
ng to a blood urea nitrogen level of 180 mg/100 mL, concentrations seen in
uremic patients. iNOS protein expression showed a dose-dependent reduction,
as revealed by immunoblotting when cells were incubated with increasing am
ounts of urea. The decrease of cytosolic DNA fragments in stimulated macrop
hages incubated with urea shows that the proliferative actions of urea are
associated with a decrease of diminished NO-mediated apoptosis.
Conclusions. These data demonstrate that inhibition of iNOS-dependent NO pr
oduction caused by urea enhances macrophage proliferation as a consequence
of diminished NO-mediated apoptosis. This fact may be important for the dev
elopment of atherosclerotic lesions during chronic renal failure and is in
accordance with recently published studies showing that under conditions wi
th decreased constitutive NOS activity, iNOS might substitute the synthesis
of NO. iNOS expression in vascular smooth muscle cells and macrophages is
supposed to prevent restenosis following angioplasty or heart transplant va
sculopathy. This is supported by the fact that specific inhibition of endog
enous iNOS activity with L-N-6-(1-iminoethly)-lysine accelerates the progre
ssion of vasculopathy in transplantation atherosclerosis.